Clinical Study Comparing Expedial and ePTFE Vascular Access Grafts

LeMaitre Vascular8 sites in 1 country172 target enrollmentMarch 2004

ConditionsEnd Stage Renal Disease

Overview

Phase: Phase 2
Intervention: Not specified
Conditions: End Stage Renal Disease
Sponsor: LeMaitre Vascular
Enrollment: 172
Locations: 8
Primary Endpoint: Primary or assisted primary patency at 1 year
Status: Terminated
Last Updated: last year

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study is to establish the substantial equivalence of Expedial and ePTFE grafts for effectiveness in maintaining primary or assisted primary patency.

Registry

clinicaltrials.gov

Start Date

March 2004

End Date

November 2006

Last Updated

last year

Study Type

Interventional

Study Design

Single Group

Sex

All

Investigators

Sponsor

LeMaitre Vascular

Eligibility Criteria

Inclusion Criteria

•Patient has chronic renal failure and requires vascular access for hemodialysis
•Patient has given informed consent to participate in the trial and is willing to comply with the study protocol
•Patient is male or female, 18 years of age or older
•The vascular access graft can be placed in the upper extremity (forearm, including across the elbow, or upper arm)
•Patient is undergoing or will undergo hemodialysis at a hospital or hemodialysis center
•Patient has a vein 4 mm or larger to which the graft can be anastomosed

Exclusion Criteria

•Patient is unable to comply with the study follow-up
•Patient has a known sensitivity to polyurethane or porcine heparin
•Patient has a previous vascular access graft implanted and it is not possible to place the study graft proximal to the existing device and no other sites are available
•Patient has an immunodeficiency syndrome
•Patient has a prior history of bacterial infection within 8 weeks of implantation of graft
•Patient has a severe coagulation disorder
•Patient has an elevated platelet count of greater than 1 million
•Patient has a history of heparin-induced thrombocytopenia syndrome (HIT)
•Patient is pregnant
•Patient has a fever greater than 100 degrees Fahrenheit